Skip to main content
Clinical Trials/NCT02365376
NCT02365376
Unknown
N/A

Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

BioMarin Pharmaceutical1 site in 1 countryJune 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rare Genetic Disorders
Sponsor
BioMarin Pharmaceutical
Locations
1
Primary Endpoint
continuous collection of donated study subject samples
Last Updated
11 years ago

Overview

Brief Summary

The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
TBD
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Willing and able to provide written, signed informed consent
  • Willing and able to comply with all study procedures

Exclusion Criteria

  • Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study
  • Concurrent disease or condition that would interfere with study participation or safety.

Outcomes

Primary Outcomes

continuous collection of donated study subject samples

Time Frame: unknown, continuous sample collection

Study Sites (1)

Loading locations...

Similar Trials